Left atrial dilatation is associated with severe ischemic stroke in men with non-valvular atrial fibrillation

Tae-Won Kim1, Sung-Woo Jung1, In-Uk Song1

  • 1Department of Neurology,College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Insights

Increased left atrial volume predicts worse stroke severity in patients with non-valvular atrial fibrillation (NVAF). Left atrial enlargement, particularly in men, is linked to more severe initial neurologic deficits, highlighting the importance of recognizing atrial abnormalities.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Imaging

Background:

  • Non-valvular atrial fibrillation (NVAF) is a significant risk factor for ischemic stroke.
  • Increased left atrial volume is a known predictor of cardiovascular events in NVAF patients.
  • The relationship between left atrial size and ischemic stroke severity or lesion patterns remains under-investigated.

Purpose of the Study:

  • To investigate the association between left atrial enlargement and initial ischemic stroke severity.
  • To determine if left atrial diameter (LAD) and left atrial volume index (LAVI) correlate with stroke severity.
  • To explore the relationship between atrial abnormalities and ischemic lesion patterns in NVAF patients.

Main Methods:

  • Recruited anticoagulation-naïve patients with acute ischemic stroke and NVAF.
  • Stratified patients into moderate-to-severe (NIHSS≥10) and mild neurologic deficit groups.
  • Compared LAD and LAVI between groups, analyzing correlations with National Institutes of Health Stroke Scale (NIHSS) scores and lesion patterns.

Main Results:

  • Increased LAD and LAVI were significantly associated with moderate-to-severe neurologic deficits, particularly in men.
  • Men with higher LAD and LAVI tertiles exhibited more severe stroke symptoms.
  • LAVI showed a significant positive correlation with NIHSS scores in all patients (r=0.215; p=0.045).

Conclusions:

  • Left atrial enlargement (increased LAD and LAVI) is linked to worse initial neurologic deficits in acute ischemic stroke patients with NVAF, especially men.
  • Early identification of atrial abnormalities is crucial.
  • Effective anticoagulation strategies may mitigate thrombogenesis in NVAF.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
966
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.5K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
485
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
559
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
482
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790